FLOW CHARACTERISTICS OF AORTIC CANNULAE

被引：30

作者：

MUEHRCKE, DD

CORNHILL, JF

THOMAS, JD

COSGROVE, DM

机构：

[1] Departments of Thoracic and Cardiovascular Surgery, Research Institute, Cleveland, Ohio

[2] Departments of Biomedical Engineering, Research Institute, Cleveland, Ohio

[3] Departments of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio

来源：

JOURNAL OF CARDIAC SURGERY | 1995年 / 10卷 / 04期

关键词：

D O I：

10.1111/j.1540-8191.1995.tb00687.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atheroembolism from the ascending aorta is an emerging cause of noncardiac complications after open heart surgery. We designed a new arterial cannula specifically to reduce the exit force and velocity of blood flow, thereby reducing the ''sandblasting'' effect of the exiting blood jet. The cannula has a closed tip and an internal cone that diffuses blood flow such that it enters the aorta via multiple side holes. Fluid dynamics of the cannula were tested against five frequently used cannulae: Sarns High-Flow (3M(TM) Sarns(TM) High-Flow, Ann Arbor, MI, USA), DLP 83024 (DLP Inc., Grand Rapids, MI, USA), RMI ARS 024C (Research Medical Inc. of Research Industries Corp., Midvale, UT, USA), Bard 1966 (C.R. Bard Inc., Haverhill, MA, USA), and Argyle THI (Sherwood Medical Co. Sub American Home Products Corp., St. Louis, MO, USA). All cannulae had an 8.0-mm external diameter. The new cannula demonstrated a similar pressure drop and internal tip diameter as the others. The exit force (newtons) of the Soft Flow cannula was significantly less than the Sarns High-Flow (p < 0.05), DLP (p < 0.001), RMI (p < 0.01), Bard (p < 0.001), and the Argyle (p < 0.001) cannulae. Peak velocity (cm/s) of the Soft Flow cannula was significantly less than the DLP (p < 0.01), RMI (p < 0.01), Bard (p < 0.01), and Argyle (p < 0.001). The cannulae all had similar hemolysis rates. The new arterial cannula produced the lowest exit force and flow velocity with no increase in hemolysis and may help to decrease the incidence of atheroemboli and its sequelae.

引用

页码：514 / 519

页数：6

共 14 条

[1]

BIauth CI, Cosgrove DM, Webb BW, Et al., Atheroembolism from the ascending aorta, J Thorac Cardiovasc Surg, 103, pp. 1104-1112, (1992)

[2]

Culliford AT, Colvin SB, Rohrer K, Et al., The atherosclerotic ascending aorta and transverse arch: A new technique to prevent cerebral injury during bypass‐experience with 13 patients, Ann Thorac Surg, 41, pp. 27-35, (1986)

[3]

Parker FB, Marvasti MA, Bove EL, Neurologic complications following coronary artery bypass: The role of atherosclerotic emboli, Thorac Cardiovasc Surg, 33, pp. 207-209, (1985)

[4]

Cosgrove DM, Management of the calcified aorta: An alternative method of occlusion, Ann Thorac Surg, 36, pp. 718-719, (1983)

[5]

Wareing TH, Davila-Roman VG, Barzilai B, Et al., Management of severely atherosclerotic ascending aorta during cardiac operations, J Thorac Cardiovasc Surg, 103, pp. 453-462, (1992)

[6]

Weinstein G, Killen DA, Innominate artery‐coronary artery bypass graft in a patient with calcific aortitis, J Thorac Cardiovasc Surg, 79, pp. 312-313, (1980)

[7]

Angell WW, Management of severely atherosclerotic ascending aorta during cardiac operations, (Discussion) J Thorac Cardiovasc Surg, 103, (1992)

[8]

Bonchek LI, Management of severely atherosclerotic ascending aorta during cardiac operations, (Discussion) J Thorac Cardiovasc Surg, 103, (1992)

[9]

Bar-EI Y, Goor DA, Clamping of the atherosclerotic ascending aorta during coronary artery bypass operations, J Thorac Cardiovasc Surg, 104, pp. 469-474, (1992)

[10]

Disch DL, O'Connor GT, Birkmeyer JD, Et al., Changes in patients undergoing coronary artery bypass grafting: 1987–1990, Ann Thorac Surg, 57, pp. 416-423, (1994)

← 1 2 →